See also this year's filing and all EDGAR filings for this company.
PDF Report 0001815974_2022_Anebulo_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001815974')"} |
Graph
Absolute values for 0001815974, Anebulo Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 21,653,491 |
| 4 | LiabilitiesCurrent | 110,048 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 131,585 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,343,755 |
| 9 | ResearchAndDevelopmentExpense | 2,269,998 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -26,638,801 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 21,653,491 |
| 1 | Liabilities | 241,633 |
| 2 | Expenses | 3,613,753 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 21,411,858 |
| 5 | NetIncome | -30,252,554 |
| 6 | ComprehensiveNetIncome | -30,252,554 |
| 7 | BaseVar | 26,073,839 |
| 8 | EconomicCapitalRatio | 0.601 |
Edgar->Model Mapping
Feature Distribution
Change over Time
